• Report SKU:SKU: HVR3482
  • Description
  • Table of Contents
  • Request Sample

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments. This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K., Spain and ROE), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), South America (Argentina, Brazil, Venezuela, Chile, and Peru) and Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, and Rest of MEA). Annual estimations and forecasts are provided from the year 2016 to 2027 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities. This report provides: ●  Market Sizing estimations and forecasts across the given market segments ●  Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, ) ●  Strategic recommendations in key business segments based on the market estimations ●  Regional and country level market analysis ●  Competitive landscaping of major market players ●  Company profiling covering the financials, recent activities and the future strategies

1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Anti-Viral Drugs Market by Drug Class
5.1 Introduction
5.2 Nucleotide Polymerase Inhibitors
5.3 Fusion Inhibitors
5.4 DNA Polymerase Inhibitors
5.5 Neuraminidase Inhibitors
5.6 Protease Inhibitors
5.7 Reverse Transcriptase Inhibitors
5.8 NS3 Protease

6 Anti-Viral Drugs Market by Type
6.1 Introduction
6.2 Generic
6.3 Branded

7 Anti-Viral Drugs Market by Application
7.1 Introduction
7.2 Hepatitis (B & C) Therapeutics
7.3 Herpes Therapeutics
7.4 HIV Therapeutics
7.5 Influenza Therapeutics
7.6 Pneumonia
7.7 Flu

8 Anti-Viral Drugs Market by End User
8.1 Introduction
8.2 Hospitals
8.3 Clinics
8.4 Ambulatory Surgical Centers

9 Geographical Segmentation
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 South America
9.4.1 Argentina
9.4.2 Brazil
9.4.3 Venezuela
9.4.4 Chile
9.4.5 Peru
9.5 Middle East & Africa
9.5.1 UAE
9.5.2 Saudi Arabia
9.5.3 Qatar
9.5.4 Iran
9.5.5 South Africa
9.5.6 Rest of Middle East & Africa

10 Vendor Landscaping
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiles
11.1 Abbott Healthcare
11.2 AbbVie
11.3 AstraZeneca AB
11.4 Aurobindo Pharma
11.5 Bristol-Myers-Squibb
11.6 Cipla
11.7 Dr Reddy
11.8 F. Hoffmann-La Roche AG
11.9 Gilead Sciences
11.10 GlaxoSmithKline
11.11 Johnson & Johnson
11.12 Med Immune/AstraZeneca
11.13 Merck & Co
11.14 Novartis International AG
11.15 Roche Holding AG

12 Appendix

13 Disclaimer

List of Tables
1 Global Anti-Viral Drugs Market Analysis, by Region, (2019-2027) ($MN)
2 Global Anti-Viral Drugs Market Analysis, by Drug Class, (2019-2027) ($MN)
3 Global Anti-Viral Drugs Market Analysis, by Nucleotide Polymerase Inhibitors, (2019-2027) ($MN)
4 Global Anti-Viral Drugs Market Analysis, by Fusion Inhibitors, (2019-2027) ($MN)
5 Global Anti-Viral Drugs Market Analysis, by DNA Polymerase Inhibitors, (2019-2027) ($MN)
6 Global Anti-Viral Drugs Market Analysis, by Neuraminidase Inhibitors, (2019-2027) ($MN)
7 Global Anti-Viral Drugs Market Analysis, by Protease Inhibitors, (2019-2027) ($MN)
8 Global Anti-Viral Drugs Market Analysis, by Reverse Transcriptase Inhibitors, (2019-2027) ($MN)
9 Global Anti-Viral Drugs Market Analysis, by NS3 Protease, (2019-2027) ($MN)
10 Global Anti-Viral Drugs Market Analysis, by Type, (2019-2027) ($MN)
11 Global Anti-Viral Drugs Market Analysis, by Generic, (2019-2027) ($MN)
12 Global Anti-Viral Drugs Market Analysis, by Branded, (2019-2027) ($MN)
13 Global Anti-Viral Drugs Market Analysis, by Application , (2019-2027) ($MN)
14 Global Anti-Viral Drugs Market Analysis, by Hepatitis (B & C) Therapeutics, (2019-2027) ($MN)
15 Global Anti-Viral Drugs Market Analysis, by Herpes Therapeutics, (2019-2027) ($MN)
16 Global Anti-Viral Drugs Market Analysis, by HIV Therapeutics, (2019-2027) ($MN)
17 Global Anti-Viral Drugs Market Analysis, by Influenza Therapeutics, (2019-2027) ($MN)
18 Global Anti-Viral Drugs Market Analysis, by Pneumonia, (2019-2027) ($MN)
19 Global Anti-Viral Drugs Market Analysis, by Flu, (2019-2027) ($MN)
20 Global Anti-Viral Drugs Market Analysis, by End User, (2019-2027) ($MN)
21 Global Anti-Viral Drugs Market Analysis, by Hospitals, (2019-2027) ($MN)
22 Global Anti-Viral Drugs Market Analysis, by Clinics, (2019-2027) ($MN)
23 Global Anti-Viral Drugs Market Analysis, by Ambulatory Surgical Centers, (2019-2027) ($MN)
24 North America Anti-Viral Drugs Market Analysis, by Country, (2019-2027) ($MN)
25 North America Anti-Viral Drugs Market Analysis, by Drug Class, (2019-2027) ($MN)
26 North America Anti-Viral Drugs Market Analysis, by Nucleotide Polymerase Inhibitors, (2019-2027) ($MN)
27 North America Anti-Viral Drugs Market Analysis, by Fusion Inhibitors, (2019-2027) ($MN)
28 North America Anti-Viral Drugs Market Analysis, by DNA Polymerase Inhibitors, (2019-2027) ($MN)
29 North America Anti-Viral Drugs Market Analysis, by Neuraminidase Inhibitors, (2019-2027) ($MN)
30 North America Anti-Viral Drugs Market Analysis, by Protease Inhibitors, (2019-2027) ($MN)
31 North America Anti-Viral Drugs Market Analysis, by Reverse Transcriptase Inhibitors, (2019-2027) ($MN)
32 North America Anti-Viral Drugs Market Analysis, by NS3 Protease, (2019-2027) ($MN)
33 North America Anti-Viral Drugs Market Analysis, by Type, (2019-2027) ($MN)
34 North America Anti-Viral Drugs Market Analysis, by Generic, (2019-2027) ($MN)
35 North America Anti-Viral Drugs Market Analysis, by Branded, (2019-2027) ($MN)
36 North America Anti-Viral Drugs Market Analysis, by Application , (2019-2027) ($MN)
37 North America Anti-Viral Drugs Market Analysis, by Hepatitis (B & C) Therapeutics, (2019-2027) ($MN)
38 North America Anti-Viral Drugs Market Analysis, by Herpes Therapeutics, (2019-2027) ($MN)
39 North America Anti-Viral Drugs Market Analysis, by HIV Therapeutics, (2019-2027) ($MN)
40 North America Anti-Viral Drugs Market Analysis, by Influenza Therapeutics, (2019-2027) ($MN)
41 North America Anti-Viral Drugs Market Analysis, by Pneumonia, (2019-2027) ($MN)
42 North America Anti-Viral Drugs Market Analysis, by Flu, (2019-2027) ($MN)
43 North America Anti-Viral Drugs Market Analysis, by End User, (2019-2027) ($MN)
44 North America Anti-Viral Drugs Market Analysis, by Hospitals, (2019-2027) ($MN)
45 North America Anti-Viral Drugs Market Analysis, by Clinics, (2019-2027) ($MN)
46 North America Anti-Viral Drugs Market Analysis, by Ambulatory Surgical Centers, (2019-2027) ($MN)
47 Europe Anti-Viral Drugs Market Analysis, by Country, (2019-2027) ($MN)
48 Europe Anti-Viral Drugs Market Analysis, by Drug Class, (2019-2027) ($MN)
49 Europe Anti-Viral Drugs Market Analysis, by Nucleotide Polymerase Inhibitors, (2019-2027) ($MN)
50 Europe Anti-Viral Drugs Market Analysis, by Fusion Inhibitors, (2019-2027) ($MN)
51 Europe Anti-Viral Drugs Market Analysis, by DNA Polymerase Inhibitors, (2019-2027) ($MN)
52 Europe Anti-Viral Drugs Market Analysis, by Neuraminidase Inhibitors, (2019-2027) ($MN)
53 Europe Anti-Viral Drugs Market Analysis, by Protease Inhibitors, (2019-2027) ($MN)
54 Europe Anti-Viral Drugs Market Analysis, by Reverse Transcriptase Inhibitors, (2019-2027) ($MN)
55 Europe Anti-Viral Drugs Market Analysis, by NS3 Protease, (2019-2027) ($MN)
56 Europe Anti-Viral Drugs Market Analysis, by Type, (2019-2027) ($MN)
57 Europe Anti-Viral Drugs Market Analysis, by Generic, (2019-2027) ($MN)
58 Europe Anti-Viral Drugs Market Analysis, by Branded, (2019-2027) ($MN)
59 Europe Anti-Viral Drugs Market Analysis, by Application , (2019-2027) ($MN)
60 Europe Anti-Viral Drugs Market Analysis, by Hepatitis (B & C) Therapeutics, (2019-2027) ($MN)
61 Europe Anti-Viral Drugs Market Analysis, by Herpes Therapeutics, (2019-2027) ($MN)
62 Europe Anti-Viral Drugs Market Analysis, by HIV Therapeutics, (2019-2027) ($MN)
63 Europe Anti-Viral Drugs Market Analysis, by Influenza Therapeutics, (2019-2027) ($MN)
64 Europe Anti-Viral Drugs Market Analysis, by Pneumonia, (2019-2027) ($MN)
65 Europe Anti-Viral Drugs Market Analysis, by Flu, (2019-2027) ($MN)
66 Europe Anti-Viral Drugs Market Analysis, by End User, (2019-2027) ($MN)
67 Europe Anti-Viral Drugs Market Analysis, by Hospitals, (2019-2027) ($MN)
68 Europe Anti-Viral Drugs Market Analysis, by Clinics, (2019-2027) ($MN)
69 Europe Anti-Viral Drugs Market Analysis, by Ambulatory Surgical Centers, (2019-2027) ($MN)
70 Asia Pacific Anti-Viral Drugs Market Analysis, by Country, (2019-2027) ($MN)
71 Asia Pacific Anti-Viral Drugs Market Analysis, by Drug Class, (2019-2027) ($MN)
72 Asia Pacific Anti-Viral Drugs Market Analysis, by Nucleotide Polymerase Inhibitors, (2019-2027) ($MN)
73 Asia Pacific Anti-Viral Drugs Market Analysis, by Fusion Inhibitors, (2019-2027) ($MN)
74 Asia Pacific Anti-Viral Drugs Market Analysis, by DNA Polymerase Inhibitors, (2019-2027) ($MN)
75 Asia Pacific Anti-Viral Drugs Market Analysis, by Neuraminidase Inhibitors, (2019-2027) ($MN)
76 Asia Pacific Anti-Viral Drugs Market Analysis, by Protease Inhibitors, (2019-2027) ($MN)
77 Asia Pacific Anti-Viral Drugs Market Analysis, by Reverse Transcriptase Inhibitors, (2019-2027) ($MN)
78 Asia Pacific Anti-Viral Drugs Market Analysis, by NS3 Protease, (2019-2027) ($MN)
79 Asia Pacific Anti-Viral Drugs Market Analysis, by Type, (2019-2027) ($MN)
80 Asia Pacific Anti-Viral Drugs Market Analysis, by Generic, (2019-2027) ($MN)
81 Asia Pacific Anti-Viral Drugs Market Analysis, by Branded, (2019-2027) ($MN)
82 Asia Pacific Anti-Viral Drugs Market Analysis, by Application , (2019-2027) ($MN)
83 Asia Pacific Anti-Viral Drugs Market Analysis, by Hepatitis (B & C) Therapeutics, (2019-2027) ($MN)
84 Asia Pacific Anti-Viral Drugs Market Analysis, by Herpes Therapeutics, (2019-2027) ($MN)
85 Asia Pacific Anti-Viral Drugs Market Analysis, by HIV Therapeutics, (2019-2027) ($MN)
86 Asia Pacific Anti-Viral Drugs Market Analysis, by Influenza Therapeutics, (2019-2027) ($MN)
87 Asia Pacific Anti-Viral Drugs Market Analysis, by Pneumonia, (2019-2027) ($MN)
88 Asia Pacific Anti-Viral Drugs Market Analysis, by Flu, (2019-2027) ($MN)
89 Asia Pacific Anti-Viral Drugs Market Analysis, by End User, (2019-2027) ($MN)
90 Asia Pacific Anti-Viral Drugs Market Analysis, by Hospitals, (2019-2027) ($MN)
91 Asia Pacific Anti-Viral Drugs Market Analysis, by Clinics, (2019-2027) ($MN)
92 Asia Pacific Anti-Viral Drugs Market Analysis, by Ambulatory Surgical Centers, (2019-2027) ($MN)
93 South America Anti-Viral Drugs Market Analysis, by Country, (2019-2027) ($MN)
94 South America Anti-Viral Drugs Market Analysis, by Drug Class, (2019-2027) ($MN)
95 South America Anti-Viral Drugs Market Analysis, by Nucleotide Polymerase Inhibitors, (2019-2027) ($MN)
96 South America Anti-Viral Drugs Market Analysis, by Fusion Inhibitors, (2019-2027) ($MN)
97 South America Anti-Viral Drugs Market Analysis, by DNA Polymerase Inhibitors, (2019-2027) ($MN)
98 South America Anti-Viral Drugs Market Analysis, by Neuraminidase Inhibitors, (2019-2027) ($MN)
99 South America Anti-Viral Drugs Market Analysis, by Protease Inhibitors, (2019-2027) ($MN)
100 South America Anti-Viral Drugs Market Analysis, by Reverse Transcriptase Inhibitors, (2019-2027) ($MN)
101 South America Anti-Viral Drugs Market Analysis, by NS3 Protease, (2019-2027) ($MN)
102 South America Anti-Viral Drugs Market Analysis, by Type, (2019-2027) ($MN)
103 South America Anti-Viral Drugs Market Analysis, by Generic, (2019-2027) ($MN)
104 South America Anti-Viral Drugs Market Analysis, by Branded, (2019-2027) ($MN)
105 South America Anti-Viral Drugs Market Analysis, by Application , (2019-2027) ($MN)
106 South America Anti-Viral Drugs Market Analysis, by Hepatitis (B & C) Therapeutics, (2019-2027) ($MN)
107 South America Anti-Viral Drugs Market Analysis, by Herpes Therapeutics, (2019-2027) ($MN)
108 South America Anti-Viral Drugs Market Analysis, by HIV Therapeutics, (2019-2027) ($MN)
109 South America Anti-Viral Drugs Market Analysis, by Influenza Therapeutics, (2019-2027) ($MN)
110 South America Anti-Viral Drugs Market Analysis, by Pneumonia, (2019-2027) ($MN)
111 South America Anti-Viral Drugs Market Analysis, by Flu, (2019-2027) ($MN)
112 South America Anti-Viral Drugs Market Analysis, by End User, (2019-2027) ($MN)
113 South America Anti-Viral Drugs Market Analysis, by Hospitals, (2019-2027) ($MN)
114 South America Anti-Viral Drugs Market Analysis, by Clinics, (2019-2027) ($MN)
115 South America Anti-Viral Drugs Market Analysis, by Ambulatory Surgical Centers, (2019-2027) ($MN)
116 Middle East & Africa Anti-Viral Drugs Market Analysis, by Country, (2019-2027) ($MN)
117 Middle East & Africa Anti-Viral Drugs Market Analysis, by Drug Class, (2019-2027) ($MN)
118 Middle East & Africa Anti-Viral Drugs Market Analysis, by Nucleotide Polymerase Inhibitors, (2019-2027) ($MN)
119 Middle East & Africa Anti-Viral Drugs Market Analysis, by Fusion Inhibitors, (2019-2027) ($MN)
120 Middle East & Africa Anti-Viral Drugs Market Analysis, by DNA Polymerase Inhibitors, (2019-2027) ($MN)
121 Middle East & Africa Anti-Viral Drugs Market Analysis, by Neuraminidase Inhibitors, (2019-2027) ($MN)
122 Middle East & Africa Anti-Viral Drugs Market Analysis, by Protease Inhibitors, (2019-2027) ($MN)
123 Middle East & Africa Anti-Viral Drugs Market Analysis, by Reverse Transcriptase Inhibitors, (2019-2027) ($MN)
124 Middle East & Africa Anti-Viral Drugs Market Analysis, by NS3 Protease, (2019-2027) ($MN)
125 Middle East & Africa Anti-Viral Drugs Market Analysis, by Type, (2019-2027) ($MN)
126 Middle East & Africa Anti-Viral Drugs Market Analysis, by Generic, (2019-2027) ($MN)
127 Middle East & Africa Anti-Viral Drugs Market Analysis, by Branded, (2019-2027) ($MN)
128 Middle East & Africa Anti-Viral Drugs Market Analysis, by Application , (2019-2027) ($MN)
129 Middle East & Africa Anti-Viral Drugs Market Analysis, by Hepatitis (B & C) Therapeutics, (2019-2027) ($MN)
130 Middle East & Africa Anti-Viral Drugs Market Analysis, by Herpes Therapeutics, (2019-2027) ($MN)
131 Middle East & Africa Anti-Viral Drugs Market Analysis, by HIV Therapeutics, (2019-2027) ($MN)
132 Middle East & Africa Anti-Viral Drugs Market Analysis, by Influenza Therapeutics, (2019-2027) ($MN)
133 Middle East & Africa Anti-Viral Drugs Market Analysis, by Pneumonia, (2019-2027) ($MN)
134 Middle East & Africa Anti-Viral Drugs Market Analysis, by Flu, (2019-2027) ($MN)
135 Middle East & Africa Anti-Viral Drugs Market Analysis, by End User, (2019-2027) ($MN)
136 Middle East & Africa Anti-Viral Drugs Market Analysis, by Hospitals, (2019-2027) ($MN)
137 Middle East & Africa Anti-Viral Drugs Market Analysis, by Clinics, (2019-2027) ($MN)
138 Middle East & Africa Anti-Viral Drugs Market Analysis, by Ambulatory Surgical Centers, (2019-2027) ($MN)